Enhanced Peripheral Chemoreflex Drive Is Associated with Cardiorespiratory Disorders in Mice with Coronary Heart

Liena Bravo1, Katherin V Pereyra1, Hugo S Diaz1

  • 1Laboratory of Cardiorespiratory Control, Pontificia Universidad Católica de Chile, Santiago, Chile.

Insights

Coronary heart disease (CHD) enhances carotid body (CB) chemoreflex drive, leading to increased cardiac sympathoexcitation and breathing disorders in mice. These findings suggest CBs play a role in cardiorespiratory changes associated with CHD.

Area of Science:

  • Cardiovascular Physiology
  • Neuroscience
  • Respiratory Medicine

Background:

  • Coronary heart disease (CHD) involves reduced coronary blood flow due to lipid deposition and oxidation.
  • Dyslipidemia in CHD is linked to oxidative stress, inflammation, and potential effects on carotid bodies (CBs).
  • The role of CB-mediated chemoreflex in CHD pathophysiology remains unclear.

Purpose of the Study:

  • To investigate the impact of CHD on peripheral CB-mediated chemoreflex drive.
  • To assess cardiac autonomic function and breathing disorders in a murine model of CHD.
  • To determine the relationship between CB chemoreflex and cardiorespiratory alterations in CHD.

Main Methods:

  • Utilized a murine model of coronary heart disease (CHD).
  • Evaluated peripheral CB-mediated chemoreflex drive, specifically the hypoxic ventilatory response.
  • Assessed cardiac autonomic function and breathing patterns in CHD mice compared to controls.

Main Results:

  • CHD mice exhibited a twofold increase in hypoxic ventilatory response, indicating enhanced CB chemoreflex drive.
  • CHD mice displayed increased cardiac sympathoexcitation and irregular breathing disorders.
  • The observed cardiorespiratory alterations were closely associated with the enhanced CB chemoreflex drive.

Conclusions:

  • Mice with CHD demonstrate an enhanced carotid body (CB) chemoreflex.
  • Increased CB activity contributes to cardiac sympathoexcitation and disordered breathing in CHD.
  • Carotid bodies (CBs) are implicated in the chronic cardiorespiratory changes observed in coronary heart disease (CHD).